CMS figures show more than 206,000 people signed up for coverage from Feb. 15 to 28
Response to One Dose of COVID-19 Vaccine Strong for Previously Infected
Two studies show higher anti-S titers in those with previous infection and very strong T-cell responses
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
Preliminary Data in Israel Show COVID-19 Vaccines Effectively Prevent Severe Disease
National study shows reduction in ratio of COVID-19 patients requiring mechanical ventilation aged 70 years and older to those younger than 50 years
One-Third of U.S. Adults Continue to Be Hesitant About COVID-19 Vaccines
Rates of vaccine hesitancy particularly high among Black adults and Republicans, a December survey reveals
Dramatic Decline Seen in COVID-19 Cases, Deaths at U.S. Nursing Homes
82 percent decline reported in new COVID-19 cases among residents at nursing homes since the peak during the week of Dec. 20
High Dose of Vitamin D Does Not Cut COVID-19 Hospital Stay
No significant differences seen for other outcomes among patients hospitalized with moderate-to-severe disease
COVID-19 Outcomes No Worse for People With Asthma
Patients with asthma may have a lower risk for becoming infected
J&J COVID-19 Vaccine Granted Emergency Use Authorization
The single-dose Ad26 vaccine is now the third COVID-19 vaccine to be granted an EUA
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine